KURA - Kura Oncology stock jumps after positive preliminary data in leukemia trial
2024-01-30 08:00:49 ET
Kura Oncology ( NASDAQ: KURA ) shares jumped as much as 38% premarket on Tuesday after the biopharmaceutical company reported positive preliminary data from a trial evaluating its investigational drug candidate, Ziftomenib, in patients with acute myeloid leukemia (AML)....
Kura Oncology stock jumps after positive preliminary data in leukemia trial